Home › Funds › Equitable › EQ/Small Company Index Portfolio
Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000009197
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 15,261 with, 55 against, 188 abstentions (not counted as with management); 4 items carried no recommendation. Shareholder proposals: 29 FOR, 15 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Equitable | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 79.1% | 14,962 | 92.5% | 339,726 |
| Backed environmental and social shareholder proposals at US companies | n/a | 6 | 9.6% | 3,486 |
Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Equitable funds on 2,747 items (18.0% of the 15,280 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Denny's Corporation | 2026-01-13 | To approve, on a non-binding, advisory basis, certain compensation that may be paid or become payable to the Company's named executive officers that is based on or otherwise relates to the Merger. | Against | FOR — 8 of 8 Equitable funds | Against | Passed (calculated), 93.5% support |
| Anterix Inc. | 2025-08-05 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. | Against | FOR — 7 of 7 Equitable funds | Against | Approved, 84.0% support |
| Phathom Pharmaceuticals, Inc. | 2026-05-19 | To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Mark Stenhouse | Withhold | FOR — 7 of 7 Equitable funds | Against | Elected, 87.5% support |
| Phathom Pharmaceuticals, Inc. | 2026-05-19 | To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Theodore R. Schroeder | Withhold | FOR — 7 of 7 Equitable funds | Against | Elected, 90.3% support |
| Aehr Test Systems | 2025-10-20 | Election of Directors: Rhea J. Posedel | For | WITHHOLD — 6 of 6 Equitable funds | For | Elected, 92.7% support |
| Anterix Inc. | 2025-08-05 | To elect seven directors to hold office until the 2026 Annual Meeting of Stockholders and until their respective successors are elected and qualified: Mahvash Yazdi | Against | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 94.4% support |
| MarineMax, Inc. | 2026-03-03 | Election of Directors: To elect three directors, each to serve for a three-year term expiring at the 2029 annual meeting of shareholders and until the election and qualification of their respective successors in office: William Brett McGill | Against | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 76.6% support |
| MarineMax, Inc. | 2026-03-03 | To approve the amendment of our 2021 Stock-Based Compensation Plan to increase the number of shares available for issuance by 415,000 shares. | Against | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 89.4% support |
| Verastem, Inc. | 2026-05-21 | Election of Directors: Karin Tollefson | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 92.4% support |
| Latham Group, Inc. | 2026-04-30 | Election of Class II Directors: Frank J. Dellaquila | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 86.7% support |
| Latham Group, Inc. | 2026-04-30 | Election of Class II Directors: William M. Pruellage | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 81.8% support |
| ORIC Pharmaceuticals, Inc. | 2026-06-18 | To elect the two Class III directors named in the accompanying proxy statement to serve until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified or until their earlier death, resignation or removal: Mardi C. Dier | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 91.4% support |
| Daily Journal Corporation | 2026-02-24 | Election of four Directors: John B. Frank | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 97.5% support |
| Daily Journal Corporation | 2026-02-24 | Election of four Directors: Mary Conlin | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 95.1% support |
| Daily Journal Corporation | 2026-02-24 | Election of four Directors: Rasool Rayani | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 97.3% support |
| Aebi Schmidt Holding AG | 2026-05-21 | Election of the Board of Directors and the Chair of the Board of Directors Election of the Board of Directors: Patrick Schaub | Against | FOR — 6 of 6 Equitable funds | Against | — |
| Aebi Schmidt Holding AG | 2026-05-21 | Election of the Human Resources and Compensation Committee of the Board of Directors: Patrick Schaub | Against | FOR — 6 of 6 Equitable funds | Against | — |
| Bowman Consulting Group Ltd. | 2026-05-28 | Election of the two Class II directors nominated by our Board of Directors and named in the proxy statement to serve for three-year terms expiring at the 2029 Annual Meeting of Stockholders: Patricia Mulroy | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 53.3% support |
| Bowman Consulting Group Ltd. | 2026-05-28 | Election of the two Class II directors nominated by our Board of Directors and named in the proxy statement to serve for three-year terms expiring at the 2029 Annual Meeting of Stockholders: Virginia Grebbien | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 59.8% support |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Election of Directors: Harry E. Sloan | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 90.0% support |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Election of Directors: Ross Fubini | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 92.6% support |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Election of Directors: Sri Kosuri | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 92.2% support |
| Wave Life Sciences Ltd. | 2025-08-05 | To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 78.2% support |
| Investors Title Company | 2026-05-20 | Election of Directors: Tammy F. Coley | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 84.3% support |
| Investors Title Company | 2026-05-20 | Election of Directors: W. Morris Fine | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 90.9% support |
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | 2026-06-10 | To elect Gregory B. Brown, M.D., John S. Cochran and Abigail L. Jenkins as Class II members of the Board of Directors, each to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: Abigail L. Jenkins | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Aquestive Therapeutics, Inc. | 2026-06-10 | To elect Gregory B. Brown, M.D., John S. Cochran and Abigail L. Jenkins as Class II members of the Board of Directors, each to serve for a three-year term until the Company's 2029 Annual Meeting of Stockholders and until his or her successor is duly elected and qualified: John S. Cochran | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Genie Energy Ltd. | 2026-06-10 | Election of Directors: Alan Rosenthal | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 95.2% support |
| Genie Energy Ltd. | 2026-06-10 | Election of Directors: Joyce J. Mason | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 99.8% support |
| Genie Energy Ltd. | 2026-06-10 | Election of Directors: W. Wesley Perry | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 95.5% support |
| 908 Devices Inc. | 2026-06-11 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 88.5% support |
| 908 Devices Inc. | 2026-06-11 | To elect three Class III directors to hold office until the 2029 annual meeting of stockholders: Christopher Brown, Ph.D. | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 99.2% support |
| 908 Devices Inc. | 2026-06-11 | To elect three Class III directors to hold office until the 2029 annual meeting of stockholders: E. Kevin Hrusovsky | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 87.0% support |
| 908 Devices Inc. | 2026-06-11 | To elect three Class III directors to hold office until the 2029 annual meeting of stockholders: Keith L. Crandell | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 98.6% support |
| Quad/Graphics, Inc. | 2026-05-20 | Election of Directors: Beth-Ann Eason | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 94.1% support |
| Quad/Graphics, Inc. | 2026-05-20 | Election of Directors: Christopher B. Harned | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 94.2% support |
| Quad/Graphics, Inc. | 2026-05-20 | Election of Directors: Jay O. Rothman | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 94.7% support |
| Quad/Graphics, Inc. | 2026-05-20 | Election of Directors: Kathryn Quadracci Flores | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 94.1% support |
| Quad/Graphics, Inc. | 2026-05-20 | Election of Directors: Melanie A. Huet | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 93.0% support |
| Quad/Graphics, Inc. | 2026-05-20 | Election of Directors: Stephen M. Fuller | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 93.0% support |
| Tectonic Therapeutic, Inc. | 2026-06-08 | Advisory approval of the compensation of the Company's Named Executive Officers. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 99.2% support |
| Natural Gas Services Group, Inc. | 2026-06-10 | Election of Directors: J. Anthony Gallegos, Jr. | Against | FOR — 6 of 6 Equitable funds | Against | Elected, 96.6% support |
| Mayville Engineering Company, Inc. | 2026-04-21 | Election of Directors: Terms expiring at the 2029 Annual Meeting: Robert L. McCormick | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 61.8% support |
| Fennec Pharmaceuticals Inc. | 2026-06-10 | 2026 EQUITY INDUCEMENT PLAN To consider, and if deemed advisable, ratify and approve the adoption of Fennec's 2026 Equity Inducement Plan. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 94.7% support |
| Fennec Pharmaceuticals Inc. | 2026-06-10 | AMENDMENT TO 2020 EQUITY INCENTIVE PLAN To consider, and if deemed advisable, approve an increase in the number of Common Shares which are reserved for issuance under Fennec's 2020 Equity Incentive Plan. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 92.4% support |
| indie Semiconductor, Inc. | 2026-05-28 | To elect three Class II directors for terms expiring at the 2029 Annual Meeting of Stockholders: Diane Biagianti | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 84.6% support |
| indie Semiconductor, Inc. | 2026-05-28 | To elect three Class II directors for terms expiring at the 2029 Annual Meeting of Stockholders: Diane Brink | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 83.6% support |
| indie Semiconductor, Inc. | 2026-05-28 | To elect three Class II directors for terms expiring at the 2029 Annual Meeting of Stockholders: Karl-Thomas Neumann | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 98.4% support |
| Tredegar Corporation | 2026-05-08 | Non-Binding Advisory Vote to Approve Named Executive Officer Compensation. | Against | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 56.9% support |
| The Lovesac Company | 2026-06-09 | Election of Directors: Sharon Leite | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 85.7% support |
| The Lovesac Company | 2026-06-09 | To provide advisory approval of the Company's fiscal 2026 compensation for its named executive officers. | Against | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 72.5% support |
| Abeona Therapeutics Inc. | 2026-06-12 | To approve an increase in the number of shares reserved for issuance under the Second Amended and Restated Abeona Therapeutics Inc. 2023 Equity Incentive Plan from 8,400,000 to 11,500,000. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 80.7% support |
| Abeona Therapeutics Inc. | 2026-06-12 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 83.8% support |
| RCI Hospitality Holdings, Inc. | 2025-08-18 | ELECTION OF DIRECTORS OF THE COMPANY: Travis Reese | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 97.8% support |
| TriSalus Life Sciences, Inc. | 2026-05-14 | To elect the Board's two nominees for directors named as nominees in the Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation, or removal: Gary Gordon | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 92.2% support |
| TriSalus Life Sciences, Inc. | 2026-05-14 | To elect the Board's two nominees for directors named as nominees in the Proxy Statement to hold office until the 2029 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation, or removal: Mary Szela | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 92.3% support |
| Expensify, Inc. | 2026-05-22 | Approval, on an advisory basis, of the compensation of our named executive officers. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 97.9% support |
| Expensify, Inc. | 2026-05-22 | Election of Directors: Carlos Alvarez Divo | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 95.4% support |
| Expensify, Inc. | 2026-05-22 | Election of Directors: Daniel Vidal | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 95.3% support |
| Expensify, Inc. | 2026-05-22 | Election of Directors: Jason Mills | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 95.3% support |
| Bakkt, Inc. | 2026-04-17 | To adjourn the Special Meeting, if necessary or appropriate in the view of the board of directors, including to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to adopt Proposal 1. | Abstain | FOR — 6 of 6 Equitable funds | Against | — |
| Bakkt, Inc. | 2026-04-17 | To approve the issuance of shares in accordance with Sections 312.03(b), 312.03(c), and 312.03(d) of the New York Stock Exchange Listed Company Manual. | Abstain | FOR — 6 of 6 Equitable funds | Against | — |
| Vuzix Corporation | 2026-06-16 | To conduct a non-binding advisory vote for the approval of the compensation disclosed in the Proxy Statement of the Company's executive officers who are named in the Proxy Statement Summary Compensation Table. | Against | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 80.5% support |
| CSP Inc. | 2026-02-10 | Election of Directors: Anthony Folger | Withhold | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 95.9% support |
| Inseego Corp. | 2026-06-16 | Approve, in an advisory vote, the compensation paid to the Company's named executive officers, as presented in the proxy statement | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 81.0% support |
| Inseego Corp. | 2026-06-16 | Elect two directors to serve until the 2029 Annual Meeting of Stockholders.: Jeffrey Tuder | Withhold | FOR — 6 of 6 Equitable funds | Against | Elected, 85.1% support |
| Cardiff Oncology, Inc. | 2026-06-11 | Proposal to approve an amendment to the Company's 2021 Omnibus Equity Incentive Plan to increase the number of shares issuable thereunder to 15,150,000 shares from 12,150,000 shares. | Against | FOR — 6 of 6 Equitable funds | Against | Approved, 57.1% support |
| Neonode Inc. | 2026-06-17 | Election of Nominees for Class III Directors: Per Lofgren | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Aeluma, Inc. | 2026-01-15 | To re-elect the Class I directors named in this Proxy Statement to hold office for a 3-year term and until his respective successor is elected and duly qualified: Steven P. DenBaars | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Airship AI Holdings, Inc. | 2025-12-11 | Election of Directors: Amit Mital | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Airship AI Holdings, Inc. | 2025-12-11 | Election of Directors: Louis Lebedin | For | WITHHOLD — 6 of 6 Equitable funds | For | — |
| American Battery Technology Company | 2025-11-13 | To elect five directors to the Company's Board of Directors (the "Board") to serve until their respective successors are duly elected and qualified: Rick Fezell | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Aura Biosciences, Inc. | 2026-06-11 | To elect two Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: David Johnson | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Aura Biosciences, Inc. | 2026-06-11 | To elect two Class II directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Teresa Marie Bitetti | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| BETA Technologies, Inc. | 2026-06-11 | Election of Directors: General (RET) James McConville | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| BETA Technologies, Inc. | 2026-06-11 | Election of Directors: John Abele | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| BETA Technologies, Inc. | 2026-06-11 | Election of Directors: John Slattery | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| European Wax Center, Inc. | 2026-05-07 | A proposal to approve and adopt the Agreement and Plan of Merger (as it may be amended, supplemented or modified from time to time), dated as of February 9, 2026, by and among Glow Midco, LLC, a Delaware limited liability company ("Parent"), Glow Merger Sub 1, Inc., a Delaware corporation and a whol | Abstain | FOR — 6 of 6 Equitable funds | Against | — |
| European Wax Center, Inc. | 2026-05-07 | A proposal to approve one or more proposals to adjourn the Special Meeting, if necessary or appropriate, including adjournments to solicit additional proxies if there are insufficient votes at the time of the Special Meeting to approve the Merger Agreement Proposal (the "Adjournment Proposal"). | Abstain | FOR — 6 of 6 Equitable funds | Against | — |
| Flushing Financial Corporation | 2026-04-02 | A proposal to approve, on a non-binding, advisory basis, the compensation that Flushing's named executive officers may receive in connection with the mergers pursuant to agreements or arrangements with Flushing (the "Flushing compensation proposal") | Against | FOR — 6 of 6 Equitable funds | Against | — |
| Golden Entertainment, Inc. | 2026-03-31 | To consider and vote on a proposal to approve one or more adjournments of the Special Meeting, from time to time, to a later date or dates to solicit additional proxies if there are insufficient votes to adopt the Transaction Proposal at the time of the Special Meeting (the "Adjournment Proposal"). | Abstain | FOR — 6 of 6 Equitable funds | Against | Approved, 94.7% support |
| Hingham Institution for Savings | 2026-04-30 | To elect five Class II Directors named in the proxy statement, each to serve until the 2029 Annual Meeting of Stockholders, and until his or her respective successor is duly elected and qualified: Brian T. Kenner | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Hingham Institution for Savings | 2026-04-30 | To elect five Class II Directors named in the proxy statement, each to serve until the 2029 Annual Meeting of Stockholders, and until his or her respective successor is duly elected and qualified: Geoffrey C. Wilkinson, Sr. | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Hingham Institution for Savings | 2026-04-30 | To elect five Class II Directors named in the proxy statement, each to serve until the 2029 Annual Meeting of Stockholders, and until his or her respective successor is duly elected and qualified: Patrick R. Gaughen | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Innventure, Inc. | 2026-06-17 | Election of three Class II directors, Bruce Brown, James O. Donnally and Catriona Fallon, as recommended by the Nominating and Corporate Governance Committee, each being nominated to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Bruce Brown | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Kolibri Global Energy Inc. | 2026-05-04 | Re-approve Stock Option Plan | Against | FOR — 6 of 6 Equitable funds | Against | — |
| LifeMD, Inc. | 2026-06-12 | Elect seven directors to serve until the next annual meeting of stockholders and until their respective successors shall have been duly elected and qualified: Dr. Joan LaRovere, M.D. | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| LifeMD, Inc. | 2026-06-12 | To approve LifeMD's Fourth Amended and Restated 2020 Equity and Incentive Plan. | Against | FOR — 6 of 6 Equitable funds | Against | — |
| LifeMD, Inc. | 2026-06-12 | To authorize the Chairman of the Board to adjourn the Annual Meeting to a later date, if necessary or appropriate, including for purposes of soliciting additional votes in favor of any or all of the proposals or for purposes of establishing a quorum. | Against | FOR — 6 of 6 Equitable funds | Against | — |
| Lucid Diagnostics Inc. | 2026-06-24 | Election of Class B Directors: Ronald M. Sparks | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| Marine Products Corporation | 2026-05-12 | To adjourn the Marine Products Special Meeting from time to time, if deemed by the chair of the Marine Products Special Meeting to be necessary or appropriate, including to solicit additional proxies in the event there are not sufficient votes at the time of the Marine Products Special Meeting to ap | Abstain | FOR — 6 of 6 Equitable funds | Against | — |
| Marine Products Corporation | 2026-05-12 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to the named executive officers of Marine Products in connection with the transactions contemplated by the merger agreement. | Against | FOR — 6 of 6 Equitable funds | Against | — |
| Performant Healthcare, Inc. | 2025-10-17 | Non-Binding, Advisory Vote on Named Executive Officers Merger-Related Compensation | Against | FOR — 6 of 6 Equitable funds | Against | — |
| Piedmont Lithium Inc. | 2025-08-22 | To adopt the Agreement and Plan of Merger, dated as of November 18, 2024 (as it may be further amended from time to time, the "merger agreement"), by and among Sayona Mining Limited, Shock MergeCo Inc., and Piedmont Lithium Inc. | Abstain | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 97.7% support |
| Piedmont Lithium Inc. | 2025-08-22 | To postpone or adjourn the Special Meeting, from time to time, to a later date or dates, if necessary or appropriate, including to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the Special Meeting. | Abstain | FOR — 6 of 6 Equitable funds | Against | Passed (calculated), 93.2% support |
| Satellogic Inc. | 2026-06-03 | Election of Directors: Miguel Gutierrez | Withhold | FOR — 6 of 6 Equitable funds | Against | — |
| SunPower, Inc. | 2026-03-25 | To approve, for purposes of complying with Nasdaq Listing Rule 5635(a), the issuance of shares of the Company's Common Stock as post-closing pursuant to the Membership Interest Purchase Agreement, dated as of November 21, 2025, by and among SunPower Inc., Ambia Holdings, Inc. and Ambia Energy, LLC i | Against | FOR — 6 of 6 Equitable funds | Against | — |
| Synchronoss Technologies, Inc. | 2026-02-12 | To adjourn the Special Meeting to a later date or dates if necessary or appropriate to solicit additional proxies if there are insufficient votes to adopt the Merger Agreement at the time of the special meeting of stockholders of Synchronoss. | Abstain | FOR — 6 of 6 Equitable funds | Against | — |
| Synchronoss Technologies, Inc. | 2026-02-12 | To approve the adoption of the Agreement and Plan of Merger (as it may be amended from time to time), dated December 3, 2025, by and among Synchronoss Technologies, Inc. ("Synchronoss"), Lumine Group US Holdco Inc. ("Parent") and Skyfall Merger Sub Inc. ("Merger Sub"), pursuant to which Merger Sub w | Abstain | FOR — 6 of 6 Equitable funds | Against | — |
| Tango Therapeutics, Inc. | 2026-06-04 | Election of Class II Directors: Mace Rothenberg, M.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 79.8% support |
| MBX Biosciences, Inc. | 2026-06-04 | Election of two Class II Directors, each to serve until the Company's 2029 Annual Meeting of Stockholders or until such person's successor is duly elected and qualified, or until their earlier death, resignation or removal: Patrick J. Heron | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 88.4% support |
| The Buckle, Inc. | 2026-06-01 | Election of Directors: Karen B. Rhoads | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 69.8% support |
| Flowco Holdings Inc. | 2026-05-07 | The election of two Class I directors to serve until the 2029 Annual Meeting of Stockholders and until his/her successors are duly elected and qualified: Cynthia L. Walker | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.5% support |
| Sonida Senior Living, Inc. | 2026-02-26 | Proposal to approve an amendment to the Amended and Restated Certificate of Incorporation of SNDA, as amended (the "SNDA Charter"), to increase the number of shares of SNDA Common Stock that SNDA is authorized to issue from 30,000,000 to 100,000,000 shares, in the form attached as Annex D (the "Auth | Abstain | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.1% support |
| Sonida Senior Living, Inc. | 2026-02-26 | Proposal to approve the adjournment of the SNDA Special Meeting, if necessary, to permit the solicitation of additional proxies in the event that there are insufficient votes on the Authorized Share Increase Proposal and the Stock Issuance Proposal presented to SNDA stockholders (the "SNDA Adjournme | Abstain | FOR — 5 of 5 Equitable funds | Against | — |
| Sonida Senior Living, Inc. | 2026-02-26 | Proposal to approve the issuance of shares of SNDA Common Stock to (i) holders of CHP common stock pursuant to the Merger Agreement, and (ii) certain affiliates of Conversant Capital LLC and Silk Partners, LP ("Silk"), pursuant to certain investment agreements entered into by SNDA in connection with | Abstain | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 100.0% support |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Arthur T. Sands, M.D., Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 79.6% support |
| Nurix Therapeutics, Inc. | 2026-05-15 | Election of Class III Directors: Paul M. Silva | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 74.2% support |
| Atlanticus Holdings Corporation | 2026-05-07 | To elect seven directors for terms expiring at the 2027 Annual Meeting of Shareholders: David G. Hanna | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 100.0% support |
| Atlanticus Holdings Corporation | 2026-05-07 | To elect seven directors for terms expiring at the 2027 Annual Meeting of Shareholders: Jeffrey A. Howard | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 100.0% support |
| Pursuit Attractions & Hospitality, Inc. | 2026-06-04 | Elect two Class I directors, to serve until the 2029 annual meeting of shareholders: Jill H. Bright | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 79.5% support |
| Pursuit Attractions & Hospitality, Inc. | 2026-06-04 | Elect two Class I directors, to serve until the 2029 annual meeting of shareholders: Joshua E. Schechter | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.0% support |
| Tyra Biosciences, Inc. | 2026-05-28 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Habib J. Dable | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.9% support |
| Tyra Biosciences, Inc. | 2026-05-28 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Robert More | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 91.7% support |
| Tyra Biosciences, Inc. | 2026-05-28 | To elect three directors to serve as Class II directors for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Susan Moran, M.D., M.S.C.E. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.6% support |
| Rapport Therapeutics, Inc. | 2026-06-10 | To elect James Healy, M.D., Ph.D., Robert J. Perez, and Raymond Sanchez, M.D. as Class II Directors: Robert J. Perez | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Allient Inc. | 2026-05-06 | TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: M.R. Winter | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.0% support |
| Allient Inc. | 2026-05-06 | TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: N.R. Tzetzo | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.9% support |
| Allient Inc. | 2026-05-06 | TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: R.B. Engel | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.6% support |
| Allient Inc. | 2026-05-06 | TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: R.D. Federico | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.5% support |
| Allient Inc. | 2026-05-06 | TO ELECT SIX DIRECTORS TO HOLD OFFICE UNTIL THE NEXT ANNUAL MEETING OF SHAREHOLDERS: S.C. Finch | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.4% support |
| CRA International, Inc. | 2025-07-17 | To consider and vote upon the election of two Class III Directors: Paul Maleh | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.1% support |
| CRA International, Inc. | 2025-07-17 | To consider and vote upon the election of two Class III Directors: Thomas Avery | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.4% support |
| UroGen Pharma Ltd. | 2026-06-22 | To approve the amendment and restatement of the Articles of Association of the Company to, among other things, tie eligibility for shareholder proposals to the requirements under the Israeli Companies Law. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 68.2% support |
| UroGen Pharma Ltd. | 2026-06-22 | To elect to the Board of Directors each of the following seven nominees presented by the Board of Directors to hold office until the Company's next annual meeting of shareholders: Arie Belldegrun, M.D. | For | AGAINST — 5 of 5 Equitable funds | For | Elected, 82.5% support |
| Omeros Corporation | 2026-06-18 | Approval of the Amended and Restated Omeros Corporation Omnibus Incentive Compensation Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 61.1% support |
| Omeros Corporation | 2026-06-18 | Election of Directors: Thomas J. Cable | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 66.4% support |
| Bandwidth Inc. | 2026-05-28 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement; | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 75.5% support |
| Bandwidth Inc. | 2026-05-28 | To elect two Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: David A. Morken | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 81.9% support |
| Bandwidth Inc. | 2026-05-28 | To elect two Class III directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Rebecca G. Bottorff | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 77.8% support |
| Preformed Line Products Company | 2026-05-04 | To elect four directors, each for a term expiring in 2028: J. Ryan Ruhlman | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 100.0% support |
| Preformed Line Products Company | 2026-05-04 | To elect four directors, each for a term expiring in 2028: R. Steven Kestner | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 100.0% support |
| Metropolitan Bank Holding Corp. | 2026-04-29 | Election of Directors: Anthony J. Fabiano - for a 3-year term | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 92.5% support |
| Metropolitan Bank Holding Corp. | 2026-04-29 | Election of Directors: Maria Fiorini Ramirez - for a 3-year term | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 72.4% support |
| Metropolitan Bank Holding Corp. | 2026-04-29 | Election of Directors: Robert C. Patent - for a 3-year term | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 91.6% support |
| Metropolitan Bank Holding Corp. | 2026-04-29 | Election of Directors: William Reinhardt - for a 3-year term | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 92.7% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Approval of the reincorporation of the Company to the State of Texas by conversion. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 95.3% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Election of Directors: Leonard M. Sturm | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 96.8% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Election of Directors: Megha H. Parekh | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 95.6% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Election of Directors: Patrick O. Zalupski | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 98.2% support |
| Dream Finders Homes, Inc. | 2026-06-08 | Election of Directors: William W. Weatherford | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 98.0% support |
| Eagle Bancorp, Inc. | 2026-05-14 | To approve a non-binding, advisory resolution approving our named executive officer compensation. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 90.6% support |
| Heritage Insurance Holdings, Inc. | 2026-06-10 | Election of Directors: Panagiotis (Pete) Apostolou | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 82.9% support |
| Kforce Inc. | 2026-04-22 | Approve the Kforce Inc. 2026 Stock Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 87.9% support |
| Kforce Inc. | 2026-04-22 | Election of Directors: Ann E. Dunwoody | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 91.7% support |
| Kforce Inc. | 2026-04-22 | Election of Directors: Derrick D. Brooks | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 93.0% support |
| Kforce Inc. | 2026-04-22 | Election of Directors: N. John Simmons | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 93.3% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Allan H. Selig | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.1% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Amy L. Ryan | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 88.3% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Ellen-Blair Chube | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.0% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: George C. Roeth | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.7% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Lawrence E. Washow | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.5% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Michael A. Nemeroff | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.6% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Patricia J. Schmeda | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.7% support |
| Oil-Dri Corporation of America | 2025-12-09 | Election of Directors: Paul M. Hindsley | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 88.4% support |
| Bumble Inc. | 2026-06-04 | Approval, on a non-binding advisory basis, of the compensation of the named executive officers as disclosed in the Proxy Statement. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 94.5% support |
| Bumble Inc. | 2026-06-04 | The election of three Class II directors of Bumble Inc., each to serve a three-year term expiring at the 2029 Annual Meeting of Stockholders and until such director's successor is elected and qualified: Amy M. Griffin | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.1% support |
| Bumble Inc. | 2026-06-04 | The election of three Class II directors of Bumble Inc., each to serve a three-year term expiring at the 2029 Annual Meeting of Stockholders and until such director's successor is elected and qualified: R. Lynn Atchison | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.1% support |
| Bumble Inc. | 2026-06-04 | The election of three Class II directors of Bumble Inc., each to serve a three-year term expiring at the 2029 Annual Meeting of Stockholders and until such director's successor is elected and qualified: Sissie L. Hsiao | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.2% support |
| Hippo Holdings Inc. | 2026-06-02 | Elect three class II directors for a three-year term: Hugh R. Frater | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 93.2% support |
| Hippo Holdings Inc. | 2026-06-02 | Elect three class II directors for a three-year term: Lori Dickerson Fouche | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 82.4% support |
| Hippo Holdings Inc. | 2026-06-02 | Elect three class II directors for a three-year term: Richard McCathron | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.5% support |
| HealthStream, Inc. | 2026-05-28 | To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: A. Alex Jahangir | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 90.3% support |
| HealthStream, Inc. | 2026-05-28 | To elect three Class II directors (A. Alex Jahangir, Jeffrey L. McLaren, and Linda E. Rebrovick) to hold office for a term of three (3) years and until their successors have been duly elected and qualified: Linda E. Rebrovick | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 93.7% support |
| Monte Rosa Therapeutics, Inc. | 2026-06-11 | To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Andrew Schiff, M.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.0% support |
| Monte Rosa Therapeutics, Inc. | 2026-06-11 | To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Anthony Manning, Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 79.0% support |
| Monte Rosa Therapeutics, Inc. | 2026-06-11 | To elect three Class II director nominees to our board of directors, to serve until the Company's 2029 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal: Chandra P. Leo, M.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.1% support |
| Petco Health and Wellness Company, Inc. | 2026-06-30 | To approve the Second Amendment to the Company's 2021 Equity Incentive Plan to increase the number of shares of Class A Common Stock authorized for issuance under the plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 85.0% support |
| Petco Health and Wellness Company, Inc. | 2026-06-30 | To elect the four director nominees named in the proxy statement as Class III directors of the Company, each to serve for a three-year term and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation, removal, retirement or disqualification: Gar | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 82.9% support |
| Douglas Dynamics, Inc. | 2026-04-29 | Election of Directors: James L. Janik (Term expiring 2028) | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.0% support |
| Douglas Dynamics, Inc. | 2026-04-29 | Election of Directors: Joher Akolawala (Term expiring 2029) | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 91.5% support |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | Election of Directors: Alison Hannah, M.D. | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 86.2% support |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | Election of Directors: Raul Rodriguez | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 98.2% support |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | Election of Directors: Walter Moos, Ph.D. | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 97.7% support |
| Rigel Pharmaceuticals, Inc. | 2026-05-14 | To approve an amendment to our 2018 Equity Incentive Plan, as amended (the "Amended 2018 Plan"), to add an additional 500,000 shares to the number of shares of common stock authorized for issuance under the Amended 2018 Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 63.0% support |
| OrthoPediatrics Corp. | 2026-06-04 | To approve, on an advisory basis, the compensation of our executive officers who are named in the compensation disclosures in this proxy statement. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 84.8% support |
| OrthoPediatrics Corp. | 2026-06-04 | To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: David R. Pelizzon | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.8% support |
| OrthoPediatrics Corp. | 2026-06-04 | To elect four (4) directors, each to serve until the 2029 annual meeting of our stockholders: Harald Ruf | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.9% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: Benjamin S. Carson, Sr. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 81.5% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: Bradley A. Moline | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 69.3% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: D. Michael Kramer | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.1% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: David R. Parker | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.8% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: Herbert J. Schmidt | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.3% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: Joey B. Hogan | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.5% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: Rachel Parker-Hatchett | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.5% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: Tracy Rosser | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 81.5% support |
| Covenant Logistics Group, Inc. | 2026-05-13 | Election of Directors: W. Miller Welborn | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.2% support |
| Nextdoor Holdings, Inc. | 2026-06-09 | Election of Class II Director: David Sze | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.0% support |
| Arteris, Inc. | 2026-06-02 | 2 wordings Election of Class II directors whose current terms will expire at the annual meeting of stockholders to be held in 2026: Antonio J. Viana | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 75.2% support |
| Southern Missouri Bancorp, Inc. | 2025-10-20 | Election of Directors: For a term to expire in 2027: Charles R. Love | Against | FOR — 5 of 5 Equitable funds | Against | — |
| Southern Missouri Bancorp, Inc. | 2025-10-20 | Election of Directors: For a term to expire in 2028: Daniel L. Jones | Against | FOR — 5 of 5 Equitable funds | Against | — |
| Infinity Natural Resources, Inc. | 2026-06-09 | To elect eight directors to our Board of Directors: Katherine M. Gallagher | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 87.4% support |
| Forum Energy Technologies, Inc. | 2026-05-08 | Election of Directors: Evelyn M. Angelle | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.9% support |
| Forum Energy Technologies, Inc. | 2026-05-08 | Election of Directors: John A. Carrig | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.7% support |
| BlackSky Technology Inc. | 2025-09-10 | Election of Class I Directors: David DiDomenico | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.1% support |
| BlackSky Technology Inc. | 2025-09-10 | Election of Class I Directors: Magid Abraham | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 60.9% support |
| Shore Bancshares, Inc. | 2026-05-20 | Election of Directors: David S. Jones Class II (term expires 2029) | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 91.4% support |
| Shore Bancshares, Inc. | 2026-05-20 | Election of Directors: Dawn M. Willey Class II (term expires 2029) | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 94.9% support |
| Shore Bancshares, Inc. | 2026-05-20 | Election of Directors: Louis P. Jenkins, Jr. Class II (term expires 2029) | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 95.0% support |
| Shore Bancshares, Inc. | 2026-05-20 | Election of Directors: Michael B. Adams Class II (term expires 2029) | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 95.7% support |
| Peoples Financial Services Corp. | 2026-05-22 | Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Joseph Coccia | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.6% support |
| Peoples Financial Services Corp. | 2026-05-22 | Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Joseph L. DeNaples, Esquire | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.0% support |
| Peoples Financial Services Corp. | 2026-05-22 | Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Ronald G. Kukuchka | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.7% support |
| Peoples Financial Services Corp. | 2026-05-22 | Election of four directors to our Board of Directors, each to serve until the 2029 Annual Meeting of Shareholders and until his successor has been elected and qualified: Sandra L. Bodnyk | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.9% support |
| Legacy Housing Corporation | 2025-12-18 | Election of Directors: Brian J. Ferguson | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 74.8% support |
| Legacy Housing Corporation | 2025-12-18 | Election of Directors: Skyler M. Howton | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 95.0% support |
| Arrow Financial Corporation | 2026-06-03 | To elect each of the following four (4) persons as Class A directors to a term of three (3) years, each to serve until their successors have been duly elected and qualified: Class A: Daniel J. White | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 87.7% support |
| Arrow Financial Corporation | 2026-06-03 | To elect each of the following four (4) persons as Class A directors to a term of three (3) years, each to serve until their successors have been duly elected and qualified: Class A: Gregory J. Champion | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 84.1% support |
| Arrow Financial Corporation | 2026-06-03 | To elect each of the following four (4) persons as Class A directors to a term of three (3) years, each to serve until their successors have been duly elected and qualified: Class A: Mark L. Behan | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.6% support |
| Community West Bancshares | 2026-03-30 | a proposal to approve the adjournment of the special meeting to permit further solicitation of proxies in the event that an insufficient number of votes are cast to approve the CWB merger proposal (the "CWB adjournment proposal"). | Abstain | FOR — 5 of 5 Equitable funds | Against | Approved, 98.9% support |
| Community West Bancshares | 2026-03-30 | a proposal to approve the principal terms of the Agreement and Plan of Merger, dated as of December 16, 2025, between CWB and United Security Bancshares ("USB"), pursuant to which USB will merge (the "merger") with and into CWB, and the transactions contemplated therein, including the issuance of CW | Abstain | FOR — 5 of 5 Equitable funds | Against | Approved, 99.7% support |
| Cullinan Therapeutics, Inc. | 2026-06-16 | Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Nadim Ahmed | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 75.6% support |
| Cullinan Therapeutics, Inc. | 2026-06-16 | Election of the following individuals nominated to serve as Class III directors, for a three-year term ending at the annual meeting of stockholders to be held in 2029: Stephen Webster | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 74.5% support |
| Capital Bancorp, Inc. | 2026-05-28 | 2 wordings Election of Class III Directors and a Class II Director to serve for terms expiring in 2029 and 2028, respectively (Board unanimously recommends voting FOR all nominees): Nominees (Class III): Jerome R. Bailey | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 75.7% support |
| CEVA, Inc. | 2026-06-02 | To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Bernadette Andrietti | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 94.9% support |
| CEVA, Inc. | 2026-06-02 | To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Louis Silver | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 95.8% support |
| CEVA, Inc. | 2026-06-02 | To elect seven directors, as specifically set forth in the proxy statement, to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: Maria Marced | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 95.7% support |
| Natural Grocers by Vitamin Cottage, Inc. | 2026-03-04 | Election of Directors: David Rooney | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 85.7% support |
| Tiptree Inc. | 2025-12-03 | A proposal to approve one or more adjournments of the special meeting, if necessary, to solicit additional proxies, in the event that there are insufficient votes to approve the Merger Proposal. | For | AGAINST — 5 of 5 Equitable funds | For | — |
| Tiptree Inc. | 2025-12-03 | A proposal to approve the merger and the other transactions contemplated by that certain Agreement and Plan of Merger, dated as of September 26, 2025 (the "Merger Agreement"), among Tiptree Inc., a Maryland corporation, The Fortegra Group, Inc., a Delaware corporation ("Fortegra"), DB Insurance Co., | For | AGAINST — 5 of 5 Equitable funds | For | Approved, 80.7% support |
| Tiptree Inc. | 2026-04-28 | Election of three Class I Directors: Bradley E. Smith | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 77.0% support |
| Tiptree Inc. | 2026-04-28 | Election of three Class I Directors: Paul M. Friedman | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 80.3% support |
| Tiptree Inc. | 2026-04-28 | Election of three Class I Directors: Randy Maultsby | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 91.3% support |
| Tiptree Inc. | 2026-04-28 | To approve Amendment No. 2 to the 2017 Omnibus Incentive Plan to (a) extend the term of the 2017 Plan to June 6, 2037, and (b) increase the number of shares of the Company's common stock available for awards thereunder by an additional 4,000,000 shares. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 72.8% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Approval of the Fourth Amended and Restated 2020 Hovnanian Enterprises, Inc. Stock Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 91.9% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Election of Directors: Edward A. Kangas | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 89.3% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Election of Directors: J. Larry Sorsby | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.9% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Election of Directors: Joseph A. Marengi | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 89.2% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Election of Directors: Miriam Hernandez-Kakol | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 96.3% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Election of Directors: Robert B. Coutts | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.1% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Election of Directors: Robin Stone Sellers | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.3% support |
| Hovnanian Enterprises, Inc. | 2026-03-31 | Election of Directors: Vincent Pagano Jr. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 86.7% support |
| Mama's Creations, Inc. | 2025-07-03 | To elect five (5) Directors to hold office for a one-year term and until each of their respective successors are duly elected and qualified. The nominees are: Lynn Blake | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 92.5% support |
| Olema Pharmaceuticals, Inc. | 2026-06-17 | Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Andrew Rappaport | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.0% support |
| Olema Pharmaceuticals, Inc. | 2026-06-17 | Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Scott Garland | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 96.4% support |
| Olema Pharmaceuticals, Inc. | 2026-06-17 | Election of the four nominees for Class III director named in the accompanying proxy statement to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Yi Larson | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 73.4% support |
| IBEX Limited | 2025-12-05 | The Election of Directors: Mohammed Khaishgi | For | AGAINST — 5 of 5 Equitable funds | For | — |
| Park-Ohio Holdings Corp. | 2026-05-14 | Election of Directors: Dan T. Moore III | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 89.5% support |
| Park-Ohio Holdings Corp. | 2026-05-14 | Election of Directors: Howard W. Hanna IV | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.3% support |
| Park-Ohio Holdings Corp. | 2026-05-14 | Election of Directors: Patrick V. Auletta | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.6% support |
| Bankwell Financial Group, Inc. | 2026-05-20 | Election of Directors: Carl M. Porto | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 85.7% support |
| Bankwell Financial Group, Inc. | 2026-05-20 | Election of Directors: Eric J. Dale | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 89.7% support |
| Bankwell Financial Group, Inc. | 2026-05-20 | Election of Directors: Kevin D. Leitao | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 89.9% support |
| Bankwell Financial Group, Inc. | 2026-05-20 | Election of Directors: Todd H. Lampert | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 89.6% support |
| EVgo Inc. | 2026-05-14 | Election of Directors: Paul Segal | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.2% support |
| Bank7 Corp. | 2026-05-20 | Advisory vote on named executive officer compensation. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 99.0% support |
| ChoiceOne Financial Services, Inc. | 2026-05-20 | Election of Directors: Keith D. Brophy | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 92.3% support |
| ChoiceOne Financial Services, Inc. | 2026-05-20 | Election of Directors: Michelle M. Wendling | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 91.8% support |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Erez Lorber | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Kobi Altman | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Nava Swersky Sofer | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Saul Reibstein | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Sejal Shah Gulati | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Vishay Precision Group, Inc. | 2026-05-19 | Election of Directors: Ziv Shoshani | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Universal Health Realty Income Trust | 2026-06-10 | Election of Trustees: Alan B. Miller | Against | FOR — 5 of 5 Equitable funds | Against | — |
| Universal Health Realty Income Trust | 2026-06-10 | Election of Trustees: Robert F. McCadden | Against | FOR — 5 of 5 Equitable funds | Against | — |
| Bicara Therapeutics Inc. | 2026-06-09 | To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Carolyn Ng, Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 88.3% support |
| Bicara Therapeutics Inc. | 2026-06-09 | To elect two class II directors to our board of directors, to serve until the 2029 annual meeting of stockholders and until his or her successor has been duly elected and qualified, or until his or her earlier death, resignation or removal: Christopher Bowden, M.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 90.4% support |
| OppFi Inc. | 2026-06-09 | To approve, on an advisory basis, the 2025 compensation of the Company's named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 95.3% support |
| OppFi Inc. | 2026-06-09 | To elect, each for a term expiring at the 2029 Annual Meeting of Stockholders or until a successor has been duly elected and qualified, the following individuals to our Board of Directors: Theodore Schwartz | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Orange County Bancorp, Inc. | 2026-05-26 | Election of Directors: Marianna R. Kennedy (three-year term) | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.5% support |
| Orange County Bancorp, Inc. | 2026-05-26 | Election of Directors: Richard B. Rowley (three-year term) | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 96.3% support |
| Aclaris Therapeutics, Inc. | 2026-06-04 | Election of Directors: Anand Mehra, M.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 89.2% support |
| Aclaris Therapeutics, Inc. | 2026-06-04 | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying the proxy card. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 89.5% support |
| BlueLinx Holdings Inc. | 2026-05-14 | Election of Directors: Mitchell B. Lewis | For | AGAINST — 5 of 5 Equitable funds | For | Failed (calculated), 43.9% support |
| BlueLinx Holdings Inc. | 2026-05-14 | Proposal to approve an Amendment to the 2021 Long-Term Incentive Plan to increase the number of shares of common stock reserved for issuance under the plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 64.8% support |
| Ovid Therapeutics Inc. | 2025-07-09 | 2 wordings Election of Class II directors: Kevin Fitzgerald | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 75.6% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Alfred M. Rankin, Jr. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.2% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Ann A. O'Hara | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.5% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Britton T. Taplin | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.6% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Carolyn Corvi | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.1% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Claiborne R. Rankin | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.6% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Colleen R. Batcheler | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.0% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: David B.H. Williams | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.6% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Edward T. Eliopoulos | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.2% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: Gary L. Collar | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.3% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: H. Vincent Poor | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.7% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: James B. Bemowski | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.5% support |
| Hyster-Yale, Inc. | 2026-05-12 | Election of Directors: John P. Jumper | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.1% support |
| DiaMedica Therapeutics Inc. | 2026-05-20 | To elect seven persons to serve as directors until our next Annual General Meeting of Shareholders or until their respective successors are elected and qualified: Michael Giuffre, M.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.8% support |
| Ooma, Inc. | 2026-06-04 | To elect two Class II directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are elected and qualified: Russ Mann | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.9% support |
| Ooma, Inc. | 2026-06-04 | To elect two Class II directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are elected and qualified: Susan G. Butenhoff | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 67.1% support |
| American Coastal Insurance Corporation | 2026-05-26 | 4 wordings Election of Directors To be elected for terms expiring in 2028: Alec L. Poitevint, II Class B Nominee | Abstain | FOR — 5 of 5 Equitable funds | Against | Elected, 99.2% support |
| W&T Offshore, Inc. | 2026-06-03 | To amend the Company's 2023 Incentive Compensation Plan to increase the number of shares of the Company's common stock available for issuance thereunder from 10,000,000 to 22,000,000. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 81.2% support |
| Concrete Pumping Holdings, Inc. | 2026-04-15 | To elect the four Class II Director nominees: Brian Hodges | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.0% support |
| Concrete Pumping Holdings, Inc. | 2026-04-15 | To elect the four Class II Director nominees: Howard D. Morgan | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 84.9% support |
| Concrete Pumping Holdings, Inc. | 2026-04-15 | To elect the four Class II Director nominees: John M. Piecuch | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.0% support |
| Concrete Pumping Holdings, Inc. | 2026-04-15 | To elect the four Class II Director nominees: Raymond Cheesman | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.0% support |
| Rimini Street, Inc. | 2026-06-03 | Election of Class III Directors: Jay Snyder | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 86.3% support |
| Rimini Street, Inc. | 2026-06-03 | Election of Class III Directors: Seth A. Ravin | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.5% support |
| Home Bancorp, Inc. | 2026-05-12 | Election of Directors: Three-year term expiring in 2029: Chris P. Rader | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 93.6% support |
| Home Bancorp, Inc. | 2026-05-12 | Election of Directors: Two-year term expiring in 2028: Daniel G. Guidry | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.0% support |
| Solid Power, Inc. | 2026-05-20 | Approval, by a non-binding advisory vote, of the compensation of Solid Power, Inc.'s named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 84.9% support |
| Solid Power, Inc. | 2026-05-20 | Election of three Class II Directors: Aleksandra Miziolek | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 84.1% support |
| Solid Power, Inc. | 2026-05-20 | Election of three Class II Directors: MaryAnn Wright | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.9% support |
| Solid Power, Inc. | 2026-05-20 | Election of three Class II Directors: Steven Goldberg | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 87.8% support |
| Monopar Therapeutics Inc. | 2026-06-22 | Election of Directors: Christopher M. Starr | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 84.7% support |
| Monopar Therapeutics Inc. | 2026-06-22 | Election of Directors: Raymond W. Anderson | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 94.2% support |
| Monopar Therapeutics Inc. | 2026-06-22 | To approve the compensation of our named executive officers on an advisory, non-binding basis. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 87.8% support |
| Shattuck Labs, Inc. | 2025-07-10 | To elect the three Class II director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: George Golumbeski, Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.7% support |
| Shattuck Labs, Inc. | 2025-07-10 | To elect the three Class II director nominees to serve until the 2028 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Neil Gibson, Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 92.6% support |
| Dine Brands Global, Inc. | 2026-05-14 | Shareholder A stockholder proposal regarding the right of stockholders to call a special meeting of stockholders at a 15% ownership threshold. | For | AGAINST — 5 of 5 Equitable funds | Against | Not approved, 44.2% support |
| Dine Brands Global, Inc. | 2026-05-14 | Approval, on an advisory basis, to provide stockholders the right to call a special meeting of the stockholders at a 25% ownership threshold. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 71.1% support |
| Hamilton Beach Brands Holding Company | 2026-05-07 | Election of Directors: Alfred M. Rankin, Jr. | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 95.7% support |
| Hamilton Beach Brands Holding Company | 2026-05-07 | Election of Directors: J.C. Butler, Jr. | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 95.1% support |
| Hamilton Beach Brands Holding Company | 2026-05-07 | Election of Directors: James A. Ratner | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.2% support |
| Hamilton Beach Brands Holding Company | 2026-05-07 | Election of Directors: Mark R. Belgya | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.9% support |
| Hamilton Beach Brands Holding Company | 2026-05-07 | Election of Directors: Michael S. Miller | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.2% support |
| Hamilton Beach Brands Holding Company | 2026-05-07 | Election of Directors: Paul D. Furlow | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.9% support |
| Consolidated Water Co. Ltd. | 2026-06-01 | The approval of an Ordinary Resolution, attached as Exhibit A to the Proxy Statement, authorizing an increase of the share capital of the Company from (i) CI$12.5 million divided into 24,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50 e | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 95.1% support |
| Aspen Aerogels, Inc. | 2026-05-13 | Approval, on a non-binding, advisory basis, of the compensation of Aspen Aerogels, Inc.'s named executive officers, as disclosed in its Proxy Statement for the 2026 Annual Meeting. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 87.1% support |
| Aspen Aerogels, Inc. | 2026-05-13 | Election of Directors: Donald R. Young | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 90.4% support |
| Aspen Aerogels, Inc. | 2026-05-13 | Election of Directors: Steven R. Mitchell | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 89.3% support |
| Boston Omaha Corporation | 2025-08-25 | Election of Directors (other than the Class B common stock Director): Jeffrey C. Royal | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.1% support |
| Shoe Carnival, Inc. | 2026-06-10 | Election of Directors: Diane E. Randolph | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 89.3% support |
| Shoe Carnival, Inc. | 2026-06-10 | Election of Directors: J. Wayne Weaver | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 98.7% support |
| Citizens Financial Services, Inc. | 2026-04-21 | Advisory vote to approve the compensation of the Company's named executive officers as disclosed in the proxy statement. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 82.6% support |
| Citizens Financial Services, Inc. | 2026-04-21 | Election of Class 3 Directors: Janie M. Hilfiger | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Citizens Financial Services, Inc. | 2026-04-21 | Election of Class 3 Directors: Rinaldo A. DePaola | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Telos Corporation | 2026-05-07 | ELECTION OF DIRECTORS: To elect seven Directors to the Board of Directors to serve until the 2027 Annual Meeting of Stockholders or until their successors are elected and qualified: David Borland | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 80.5% support |
| Rezolute, Inc. | 2025-11-19 | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers as disclosed in the Executive Compensation section of the Proxy Statement. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 67.7% support |
| Rezolute, Inc. | 2025-11-19 | To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Gil Labrucherie | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 93.2% support |
| Rezolute, Inc. | 2025-11-19 | To elect the seven nominees to the Company's Board of Directors to serve until the 2027 Annual Meeting of Stockholders, until his or her successor is elected and shall have qualified or until his or her death, resignation, removal or disqualification: Nerissa Kreher | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 76.6% support |
| Stitch Fix, Inc. | 2025-12-11 | Election of Directors: Kofi Amoo-Gottfried | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 91.6% support |
| Stitch Fix, Inc. | 2025-12-11 | Election of Directors: Timothy Baxter | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 93.8% support |
| Regional Management Corp. | 2026-05-14 | Re-approval of the Regional Management Corp. 2024 Long-Term Incentive Plan (as amended and restated effective as of May 14, 2026). | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 83.7% support |
| Designer Brands Inc. | 2026-06-17 | Amend the provisions relating to director and officer indemnification and related matters. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 83.9% support |
| Designer Brands Inc. | 2026-06-17 | Election of Directors: Harvey L. Sonnenberg | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.0% support |
| Designer Brands Inc. | 2026-06-17 | Election of Directors: Peter S. Cobb | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 90.0% support |
| Flexsteel Industries, Inc. | 2025-12-10 | To elect two (2) Class III Directors to serve until the 2028 Annual Meeting and until their respective successors have been elected and qualified or until their earlier resignation, removal or termination: M. Scott Culbreth | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.3% support |
| First Community Corporation | 2025-11-19 | To consider and vote on a proposal to authorize the board of directors to adjourn the special meeting, if necessary or appropriate, to allow time for further solicitation of proxies in the event there are insufficient votes present at the special meeting, in person or by proxy, to approve the First | Abstain | FOR — 5 of 5 Equitable funds | Against | — |
| First Community Corporation | 2025-11-19 | To consider and vote upon a proposal to approve the Agreement and Plan of Merger dated as of July 13, 2025, by and among First Community Corporation, First Community Bank, and Signature Bank of Georgia, under which Signature Bank will be merged with and into First Community Bank, and the transaction | Abstain | FOR — 5 of 5 Equitable funds | Against | — |
| Titan International, Inc. | 2026-06-18 | To elect the following directors to serve for one-year terms and until their successors are elected and qualified: Maurice M. Taylor, Jr. | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 91.8% support |
| Titan International, Inc. | 2026-06-18 | To elect the following directors to serve for one-year terms and until their successors are elected and qualified: Max A. Guinn | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 87.0% support |
| First Western Financial, Inc. | 2026-06-03 | Advisory, non-binding vote to approve the compensation paid to the Company's named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 80.0% support |
| First Western Financial, Inc. | 2026-06-03 | Election of Directors: David R. Duncan | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.7% support |
| First Western Financial, Inc. | 2026-06-03 | Election of Directors: Julie A. Caponi | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.0% support |
| First Western Financial, Inc. | 2026-06-03 | Election of Directors: Patrick H. Hamill | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.7% support |
| Princeton Bancorp, Inc. | 2026-04-21 | the election of nine directors to the Company's board of directors, each to serve until the 2027 Annual Meeting of shareholders, and until his or her successor is elected and qualified: Judith A. Giacin | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 83.0% support |
| Princeton Bancorp, Inc. | 2026-04-21 | the election of nine directors to the Company's board of directors, each to serve until the 2027 Annual Meeting of shareholders, and until his or her successor is elected and qualified: Richard J. Gillespie | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 82.5% support |
| Princeton Bancorp, Inc. | 2026-04-21 | the election of nine directors to the Company's board of directors, each to serve until the 2027 Annual Meeting of shareholders, and until his or her successor is elected and qualified: Robert N. Ridolfi | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 82.9% support |
| Turtle Beach Corporation | 2026-06-02 | Election of Directors: Julia W. Sze | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.9% support |
| Turtle Beach Corporation | 2026-06-02 | Election of Directors: William Wyatt | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 91.5% support |
| Enanta Pharmaceuticals, Inc. | 2026-03-11 | To approve an amendment to our 2019 Equity Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 78.4% support |
| Enanta Pharmaceuticals, Inc. | 2026-03-11 | To elect two Class I directors to serve until the 2029 Annual Meeting of Stockholders or until their respective successors are elected and qualified: Bruce L.A. Carter, Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 81.4% support |
| Hawthorn Bancshares, Inc. | 2026-06-02 | ELECTION OF FOUR CLASS I DIRECTORS: Douglas T. Eden | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.9% support |
| Fulcrum Therapeutics, Inc. | 2026-06-24 | Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Alan Ezekowitz | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.3% support |
| Fulcrum Therapeutics, Inc. | 2026-06-24 | Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Colin Hill | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.3% support |
| Fulcrum Therapeutics, Inc. | 2026-06-24 | Election of three Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Sonja Banks | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 80.3% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Charles G. McClure, Jr. | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 92.3% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Claudia N. Drayton | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 90.5% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Jeffrey A. Graves | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 92.3% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Jim D. Kever | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 92.2% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: John J. Tracy | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 91.9% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Kevin S. Moore | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 91.7% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Malissia R. Clinton | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 90.3% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Thomas W. Erickson | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 91.8% support |
| 3D Systems Corporation | 2026-05-14 | The election of the nine directors named in the accompanying Proxy Statement: Vasant Padmanabhan | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 91.0% support |
| Perma-Fix Environmental Services, Inc. | 2025-07-24 | ELECTION OF DIRECTORS: Joe R. Reeder | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.7% support |
| The E.W. Scripps Company | 2026-05-04 | Election of Directors: Burton F. Jablin | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| The E.W. Scripps Company | 2026-05-04 | Election of Directors: Kim Williams | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| The E.W. Scripps Company | 2026-05-04 | Election of Directors: Marcellus W. Alexander, Jr. | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| The E.W. Scripps Company | 2026-05-04 | Election of Directors: Nishat A. Mehta | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Acme United Corporation | 2026-04-27 | Approval of an amendment to the 2022 Employee Stock Option Plan to increase the number of shares authorized for issuance as described in the Proxy Statement. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 67.8% support |
| Friedman Industries, Incorporated | 2025-09-18 | Election of Directors: J. Williams | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 88.3% support |
| M-tron Industries, Inc. | 2026-06-16 | To approve the Second Amended and Restated M-tron Industries, Inc. 2022 Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 72.4% support |
| M-tron Industries, Inc. | 2026-06-16 | To elect seven (7) directors to serve until the 2027 annual meeting of stockholders: John Mega | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 84.5% support |
| M-tron Industries, Inc. | 2026-06-16 | To elect seven (7) directors to serve until the 2027 annual meeting of stockholders: Marc Gabelli | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 72.7% support |
| iHeartMedia, Inc. | 2026-06-04 | The approval of the second amendment to the iHeartMedia, Inc. 2021 Long-Term Incentive Award Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.7% support |
| iHeartMedia, Inc. | 2026-06-04 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 84.4% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Cheryl Mills | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.3% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Graciela Monteagudo | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.8% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: James A. Rasulo | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 90.7% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Kamakshi Sivaramakrishnan | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.8% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Richard J. Bressler | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.8% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Robert Millard | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.7% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Robert W. Pittman | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.7% support |
| iHeartMedia, Inc. | 2026-06-04 | The election of the following eight director nominees, each for a one-year term ending at the 2027 Annual Meeting of Stockholders: Samuel E. Englebardt | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.7% support |
| Richardson Electronics, Ltd. | 2025-10-07 | Election of directors: Jacques Belin | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Richardson Electronics, Ltd. | 2025-10-07 | Election of directors: James Benham | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Richardson Electronics, Ltd. | 2025-10-07 | Election of directors: Kenneth Halverson | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Richardson Electronics, Ltd. | 2025-10-07 | Election of directors: Robert Kluge | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Richardson Electronics, Ltd. | 2025-10-07 | To approve an amendment to the Amended and Restated 2011 Long-Term Incentive Plan to increase the number of shares available for issuance under the Plan. | Against | FOR — 5 of 5 Equitable funds | Against | — |
| Standard BioTools Inc. | 2026-06-17 | Election of Directors: Eli Casdin | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 94.0% support |
| Standard BioTools Inc. | 2026-06-17 | Election of Directors: Thomas Carey | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 91.2% support |
| Standard BioTools Inc. | 2026-06-17 | To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 85.2% support |
| Lifecore Biomedical, Inc. | 2025-10-29 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Humberto C. Antunes | Abstain | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.0% support |
| Lifecore Biomedical, Inc. | 2025-10-29 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Matthew E. Korenberg | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.6% support |
| Lifecore Biomedical, Inc. | 2025-10-29 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Nelson Obus | Abstain | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.9% support |
| Lifecore Biomedical, Inc. | 2026-06-04 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Humberto C. Antunes | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 93.9% support |
| Lifecore Biomedical, Inc. | 2026-06-04 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Joshua E. Schechter | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 88.2% support |
| Lifecore Biomedical, Inc. | 2026-06-04 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Matthew E. Korenberg | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.7% support |
| Lifecore Biomedical, Inc. | 2026-06-04 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Nelson Obus | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.8% support |
| Lifecore Biomedical, Inc. | 2026-06-04 | To elect seven non-Series A Preferred Directors, as described in the Proxy Statement, for a term expiring at the next succeeding annual meeting of stockholders and until their successors are duly elected and qualified: Paul H. Johnson | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.8% support |
| Medallion Financial Corp. | 2026-06-09 | Shareholder ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS ZIMCAL ASSET MANAGEMENT LLC, NOMINEES: Eric Kelly | For | WITHHOLD — 5 of 5 Equitable funds | Against | Plurality election, 19.5% support |
| Medallion Financial Corp. | 2026-06-09 | ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS COMPANY NOMINEES: Cynthia Hallenbeck | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 75.9% support |
| RCM Technologies, Inc. | 2025-12-18 | Approve our 2025 Omnibus Equity Compensation Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 64.9% support |
| RCM Technologies, Inc. | 2025-12-18 | Election of four directors proposed in the accompanying proxy, each to serve one-year term and until a successor is elected and qualified: Swarna Srinivas Kakodkar | For | AGAINST — 5 of 5 Equitable funds | For | Passed (calculated), 95.0% support |
| Zumiez Inc. | 2026-06-03 | Election of Directors: Carmen R. Bauza | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.1% support |
| Zumiez Inc. | 2026-06-03 | Election of Directors: Liliana Gil Valletta | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 99.2% support |
| Zumiez Inc. | 2026-06-03 | Election of Directors: Thomas D. Campion | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 96.5% support |
| OP Bancorp | 2026-05-28 | Election of Directors Elect 7 directors to serve one-year terms expiring in 2027: Yong Sin Shin | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 92.2% support |
| Immersion Corporation | 2026-04-06 | Election of five (5) directors: Eric Singer | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 91.0% support |
| Immersion Corporation | 2026-04-06 | Election of five (5) directors: Frederick Wasch | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 87.8% support |
| Korro Bio, Inc. | 2026-06-10 | Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 82.6% support |
| Vanda Pharmaceuticals Inc. | 2026-06-04 | To elect three Class II Directors: Anne Sempowski Ward | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 88.2% support |
| Vanda Pharmaceuticals Inc. | 2026-06-04 | To elect three Class II Directors: Richard W. Dugan | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 85.9% support |
| SIGA Technologies, Inc. | 2026-06-09 | Election of Directors: Gary J. Nabel | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 91.5% support |
| SIGA Technologies, Inc. | 2026-06-09 | Election of Directors: Joseph W. Marshall, III | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 89.2% support |
| Protalix Biotherapeutics, Inc. | 2026-06-25 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement that accompanies this notice; | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 80.9% support |
| Pro-Dex, Inc. | 2025-11-20 | Election of Directors: David C. Hovda | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 91.4% support |
| Pro-Dex, Inc. | 2025-11-20 | Election of Directors: Katrina M.K. Philp | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 92.0% support |
| Pro-Dex, Inc. | 2025-11-20 | To amend the 2016 Equity Incentive Plan in order to extend its term for an additional ten years. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 92.3% support |
| Meridian Corporation | 2026-05-28 | ELECTION OF DIRECTORS. The election of three (3) directors as "Class C" directors of the Board, to serve a three-year term expiring in 2029: Edward J. Hollin | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 78.5% support |
| Alta Equipment Group Inc. | 2026-05-29 | Election of Directors: Colin Wilson | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Alta Equipment Group Inc. | 2026-05-29 | Election of Directors: Ryan Greenawalt | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Westwood Holdings Group, Inc. | 2026-04-30 | To approve the Twelfth Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 85.9% support |
| Nature's Sunshine Products, Inc. | 2026-05-06 | To approve the adoption of the Nature's Sunshine Products, Inc. 2026 Stock Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 52.6% support |
| Hudson Technologies, Inc. | 2026-06-10 | To elect a class of four directors to the Board of Directors: Eric A. Prouty | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 93.9% support |
| Hudson Technologies, Inc. | 2026-06-10 | To elect a class of four directors to the Board of Directors: Loan N. Mansy | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 93.4% support |
| Hudson Technologies, Inc. | 2026-06-10 | To elect a class of four directors to the Board of Directors: Richard Parrillo | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 93.8% support |
| Crexendo, Inc. | 2025-12-02 | To consider and vote upon a proposal for advisory approval of the compensation of the Company's named executive officers; | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 91.5% support |
| Crexendo, Inc. | 2025-12-02 | a proposal to elect six (6) directors nominated by our board of directors and named in this proxy statement: Kevin Jackson | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.4% support |
| Crexendo, Inc. | 2025-12-02 | a proposal to elect six (6) directors nominated by our board of directors and named in this proxy statement: Steven G. Mihaylo | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 94.0% support |
| The Eastern Company | 2026-05-06 | Election of Directors: James A. Mitarotonda | For | AGAINST — 5 of 5 Equitable funds | For | — |
| Epsilon Energy Ltd. | 2025-11-12 | To adjourn the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for the approval of the Share Issuance Proposal (the "Adjournment Proposal"). | Abstain | FOR — 5 of 5 Equitable funds | Against | Approved, 82.4% support |
| Epsilon Energy Ltd. | 2025-11-12 | To approve the issuance of Common Shares pursuant to the Purchase Agreements, for purposes of complying with NASDAQ Listing Rule 5635 (the "Share Issuance Proposal"). | Abstain | FOR — 5 of 5 Equitable funds | Against | — |
| Epsilon Energy Ltd. | 2026-05-20 | Election of Directors: Bryan Lawrence | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 95.8% support |
| Epsilon Energy Ltd. | 2026-05-20 | Election of Directors: David Winn | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 99.3% support |
| Epsilon Energy Ltd. | 2026-05-20 | Election of Directors: John Lovoi | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 93.6% support |
| Epsilon Energy Ltd. | 2026-05-20 | Election of Directors: Tracy Stephens | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 89.2% support |
| Energy Services of America Corporation | 2026-02-18 | Election of Directors: Joseph L. Williams | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 87.9% support |
| eGain Corporation | 2025-12-09 | Approval of the election of each of the nominated directors to serve until the 2026 annual meeting of stockholders or until their successors are elected and qualified: Gunjan Sinha | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 69.7% support |
| DMC Global Inc. | 2026-05-13 | Election of Directors: Michael A. Kelly | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 77.4% support |
| DMC Global Inc. | 2026-05-13 | Election of Directors: Ouma Sananikone | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 75.3% support |
| DMC Global Inc. | 2026-05-13 | Election of Directors: Ruth I. Dreessen | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 78.0% support |
| Medifast, Inc. | 2026-05-19 | Approve the Amended and Restated 2012 Share Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 68.9% support |
| Medifast, Inc. | 2026-05-19 | Approve, on an advisory basis, the compensation of the Company's named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 86.2% support |
| Medifast, Inc. | 2026-05-19 | Elect seven nominees to the Board of Directors to serve for a one-year term expiring in 2027: Scott Schlackman | For | AGAINST — 5 of 5 Equitable funds | For | Elected, 82.8% support |
| Mammoth Energy Services, Inc. | 2026-06-25 | Election of Directors: James Palm | For | AGAINST — 5 of 5 Equitable funds | For | Elected, 92.0% support |
| KORU Medical Systems, Inc. | 2026-05-19 | Approval of an amendment to the 2024 Omnibus Equity Incentive Plan to increase the available number of shares. | Against | FOR — 5 of 5 Equitable funds | Against | — |
| Quanterix Corporation | 2025-09-29 | Election of three director nominees to our Board to serve three-year terms expiring at the annual meeting of stockholders in 2028 or until their successors are duly elected and qualified: David R. Walt, Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 82.8% support |
| Protara Therapeutics, Inc. | 2026-06-12 | Approval of an amendment to the Protara Therapeutics, Inc. 2024 Equity Incentive Plan | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 58.6% support |
| Protara Therapeutics, Inc. | 2026-06-12 | Election of three Class III directors to the Board of Directors of Protara Therapeutics, Inc., each to hold office until the annual meeting of stockholders in 2029: Barry Flannelly, Pharm.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 82.2% support |
| Compass Therapeutics, Inc. | 2026-06-10 | To elect two class III directors to our Board of Directors, to serve until the 2029 annual meeting of stockholders and until his successor has been duly elected and qualified, or until his earlier death, resignation or removal: Richard S. Lindahl, M.B.A. | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 84.9% support |
| enCore Energy Corp. | 2026-06-10 | To elect seven directors for the ensuing year: Nathan A. Tewalt | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 98.5% support |
| enCore Energy Corp. | 2026-06-10 | To elect seven directors for the ensuing year: Susan Hoxie-Key | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 64.2% support |
| enCore Energy Corp. | 2026-06-10 | To elect seven directors for the ensuing year: William B. Harris | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 97.8% support |
| Ascent Industries Co. | 2026-06-10 | Election of Directors: Aldo J. Mazzaferro | For | AGAINST — 5 of 5 Equitable funds | For | Passed (calculated), 64.8% support |
| Akebia Therapeutics, Inc. | 2026-06-17 | Election of three Class III Directors to serve until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier death, resignation or removal: LeAnne M. Zumwalt | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 68.3% support |
| Coherus Oncology, Inc. | 2026-05-29 | To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 70.5% support |
| Coherus Oncology, Inc. | 2026-05-29 | To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Dennis M. Lanfear | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 92.7% support |
| Coherus Oncology, Inc. | 2026-05-29 | To elect two Class III directors to hold office until the 2029 Annual Meeting of Stockholders or until their successors are elected: Mats L. Wahlstrom | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 91.2% support |
| Foghorn Therapeutics Inc. | 2026-06-24 | 2 wordings Elect Class III directors each for a three-year term: Balkrishan (Simba) Gill, Ph.D. | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 99.7% support |
| SoundThinking, Inc. | 2026-06-03 | Election of Class III Directors: Marc Morial | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 87.1% support |
| SoundThinking, Inc. | 2026-06-03 | Election of Class III Directors: Ralph A. Clark | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.8% support |
| SoundThinking, Inc. | 2026-06-03 | Election of Class III Directors: Ruby Sharma | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.6% support |
| Humacyte, Inc. | 2026-06-09 | Approval, on an advisory basis, of the compensation paid to Humacyte, Inc.'s named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 67.3% support |
| Humacyte, Inc. | 2026-06-09 | Election of three Class II directors to serve until the 2029 annual meeting of stockholders: Kathleen Sebelius | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 84.7% support |
| Humacyte, Inc. | 2026-06-09 | Election of three Class II directors to serve until the 2029 annual meeting of stockholders: Keith Anthony Jones | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 84.9% support |
| Stereotaxis, Inc. | 2026-05-14 | To elect each of the following directors to serve a three-year term as a Class I director until the 2029 Annual Meeting and until their respective successors are duly elected and qualified: Dr. Myriam Curet | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.4% support |
| Stereotaxis, Inc. | 2026-05-14 | To elect each of the following directors to serve a three-year term as a Class I director until the 2029 Annual Meeting and until their respective successors are duly elected and qualified: Mr. David Benfer | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 97.5% support |
| Atomera Incorporated | 2026-05-12 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement to be filed for the Annual Meeting. | Against | FOR — 5 of 5 Equitable funds | Against | — |
| Virco Mfg. Corporation | 2026-06-16 | Election of two class I Directors: Craig L. Levra | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 83.2% support |
| Virco Mfg. Corporation | 2026-06-16 | Election of two class I Directors: Robert R. Lind | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.6% support |
| Lakeland Industries, Inc. | 2026-06-16 | Elect three directors to serve for a term of three years or until their successors have been duly elected and qualified: Melissa Kidd | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.8% support |
| Lakeland Industries, Inc. | 2026-06-16 | Elect three directors to serve for a term of three years or until their successors have been duly elected and qualified: Ronald Herring | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 96.7% support |
| Rithm Property Trust Inc. | 2026-06-02 | Election of Directors: Mary Haggerty | For | WITHHOLD — 5 of 5 Equitable funds | For | Passed (calculated), 51.7% support |
| Rithm Property Trust Inc. | 2026-06-02 | Election of Directors: Paul Friedman | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 53.1% support |
| Rithm Property Trust Inc. | 2026-06-02 | To approve (on a non-binding advisory basis) the compensation of the named executive officers as described in the accompanying materials. | Against | FOR — 5 of 5 Equitable funds | Against | Not approved, 30.7% support |
| Outset Medical, Inc. | 2026-06-04 | Election of Class III Directors: Brent D. Lang | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 75.4% support |
| Outset Medical, Inc. | 2026-06-04 | To approve, on a non-binding basis, the 2025 compensation of our named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 70.2% support |
| Siebert Financial Corp. | 2025-11-18 | Advisory vote to approve named executive compensation. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.5% support |
| BARK, Inc. | 2026-03-25 | Approve, on an advisory basis, the compensation of the company's named executive officers. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 81.1% support |
| BARK, Inc. | 2026-03-25 | Elect the two Class A director nominees named in the proxy statement: Betsy McLaughlin | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 84.3% support |
| BARK, Inc. | 2026-03-25 | Elect the two Class A director nominees named in the proxy statement: Henrik Werdelin | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 89.3% support |
| TTEC Holdings, Inc. | 2026-05-21 | Election of Director Nominees: Gregory A. Conley | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 96.5% support |
| TTEC Holdings, Inc. | 2026-05-21 | Election of Director Nominees: Robert N. Frerichs | Withhold | FOR — 5 of 5 Equitable funds | Against | Elected, 89.9% support |
| TTEC Holdings, Inc. | 2026-05-21 | The approval of the redomestication of the Company from Delaware to Texas by conversion. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 85.7% support |
| SelectQuote, Inc. | 2025-11-11 | To elect the Class III director nominees listed below for a term of three years: Denise L. Devine | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 78.7% support |
| SelectQuote, Inc. | 2025-11-11 | To elect the Class III director nominees listed below for a term of three years: Donald L. Hawks III | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 81.8% support |
| SkinHealth Systems Inc. | 2026-06-10 | Election of Directors: Brian Miller | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 78.6% support |
| LENSAR, Inc. | 2025-12-18 | Election of Class II Directors: Aimee S. Weisner | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.6% support |
| KULR Technology Group, Inc. | 2025-11-21 | Proposal to adopt the "KULR Technology Group, Inc., 2025 Equity Incentive Plan." | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 98.4% support |
| Heron Therapeutics, Inc. | 2026-06-11 | To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 84.5% support |
| Travelzoo | 2026-04-20 | To elect five members of the Company's Board of Directors (the "Board"), each to serve until the 2027 Annual Meeting of Stockholders and until their successors are elected and qualified or until their earlier resignation or removal: Volodymyr Cherevko | For | AGAINST — 5 of 5 Equitable funds | For | Passed (calculated), 93.8% support |
| Myomo, Inc. | 2026-06-25 | Elect two Class III directors, namely Paul R. Gudonis and Thomas F. Kirk, each to hold office until the 2029 annual meeting of stockholders and until his successor is duly elected and qualified, subject to his earlier resignation or removal: Thomas F. Kirk | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.9% support |
| Myomo, Inc. | 2026-06-25 | To approve any adjournments and postponements of the Annual Meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the Annual Meeting to approve Proposals 1-6; and | For | AGAINST — 5 of 5 Equitable funds | For | Approved, 84.7% support |
| Skillsoft Corp. | 2026-06-25 | To approve, on an advisory basis, the compensation of our named executive officers; | For | AGAINST — 5 of 5 Equitable funds | For | Passed (calculated), 86.3% support |
| Skillsoft Corp. | 2026-06-25 | To elect as directors the three nominees named in the accompanying Proxy Statement to a term of three years each, or until their successors have been elected and qualified: Michael S. Klein | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 92.8% support |
| SANUWAVE Health, Inc. | 2025-08-19 | Election of Directors: James Tyler | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 95.5% support |
| SANUWAVE Health, Inc. | 2025-08-19 | To approve an amendment to the SANUWAVE Health, Inc. 2024 Equity Incentive Plan to increase the number of shares authorized for issuance under the plan by 500,000 shares. | Against | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 96.1% support |
| SANUWAVE Health, Inc. | 2026-06-11 | Election of Directors: James Tyler | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 84.9% support |
| SANUWAVE Health, Inc. | 2026-06-11 | Election of Directors: Jeffrey Blizard | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 91.6% support |
| eHealth, Inc. | 2026-06-18 | Approval of an amendment and restatement of the eHealth, Inc. Amended and Restated 2024 Equity Incentive Plan to Increase the maximum number of shares of common stock that may be issued thereunder by 1,300,000 shares. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 82.3% support |
| eHealth, Inc. | 2026-06-18 | Election of Class II Directors: Beth A. Brooke | Withhold | FOR — 5 of 5 Equitable funds | Against | Passed (calculated), 82.3% support |
| aTyr Pharma, Inc. | 2026-05-11 | To elect three Class II directors, as nominated by the Company's Board of Directors (the "Board of Directors"), to hold office until the 2029 annual meeting of stockholders or until their successors are duly elected and qualified: Jane A. Gross, Ph.D. | Withhold | FOR — 5 of 5 Equitable funds | Against | — |
| Accuray Incorporated | 2025-11-13 | To approve our 2026 Equity Incentive Plan. | Against | FOR — 5 of 5 Equitable funds | Against | Approved, 87.0% support |
| Accuray Incorporated | 2025-11-13 | To elect three Class I directors named in the accompanying proxy statement to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified: Anne B. Le Grand | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 92.0% support |
| Accuray Incorporated | 2025-11-13 | To elect three Class I directors named in the accompanying proxy statement to serve until our 2028 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified: Joseph E. Whitters | Against | FOR — 5 of 5 Equitable funds | Against | Elected, 88.8% support |
2,247 more in the CSV.
Download all 2,747 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.8% of this fund’s 15,504 such votes could be given a sector; the other 1,433 (9.2%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 3,161 | 3 | 0.1% |
| Consumer Discretionary | 2,724 | 24 | 0.9% |
| Health Care | 2,435 | 11 | 0.5% |
| Industrials | 1,558 | 5 | 0.3% |
| Technology | 1,415 | 4 | 0.3% |
| Real Estate | 878 | 1 | 0.1% |
| Energy | 615 | 0 | 0.0% |
| Utilities | 378 | 0 | 0.0% |
| Consumer Staples | 255 | 5 | 2.0% |
| Basic Materials | 237 | 0 | 0.0% |
| Miscellaneous | 210 | 0 | 0.0% |
| Telecommunications | 205 | 1 | 0.5% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 10,480 | 23 |
| Say-on-Pay | 1,834 | 2 |
| Audit-related | 1,815 | 0 |
| Compensation | 632 | 0 |
| Corporate Governance | 449 | 17 |
| Capital Structure | 216 | 3 |
| Extraordinary Transactions | 203 | 3 |
| Shareholder Rights and Defenses | 48 | 1 |
| Other | 11 | 0 |
| Other Social Issues | 3 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Bloom Energy Corporation | May 21, 2026 | $21M | 8 | 0 |
| agilon health, inc. | March 17, 2026 | $20M | 2 | 0 |
| Guardant Health, Inc. | June 17, 2026 | $10M | 5 | 0 |
| Glaukos Corporation | May 28, 2026 | $8M | 4 | 0 |
| Nextracker Inc. | August 18, 2025 | $7M | 5 | 0 |
| BridgeBio Pharma, Inc. | June 22, 2026 | $7M | 7 | 0 |
| The Ensign Group, Inc. | May 13, 2026 | $6M | 6 | 0 |
| American Healthcare REIT, Inc. | June 24, 2026 | $6M | 11 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| March 9, 2026 | Sanmina Corporation | To consider and vote upon the stockholder proposal entitled "Independent Board Chairman," requesting that the Board of Directors adopt a policy and amend governing documents as necessary in order that two separate people hold the office of the Chairman and the office of the CEO. Shareholder proposal | Against | For |
| April 28, 2026 | The Brink's Company | Act upon a shareholder proposal requesting a report on employee retention rates by demographic categories. Shareholder proposal | Against | For |
| May 13, 2026 | ICU Medical, Inc. | To approve, on an advisory basis, a stockholder proposal to establish a 10% stockholder special meeting right. Shareholder proposal | For | Against |
| May 21, 2026 | Meritage Homes Corporation | Shareholder proposal to improve shareholder ability to call for a special shareholder meeting. Shareholder proposal | For | Against |
| May 4, 2026 | Asbury Automotive Group, Inc. | Stockholder proposal regarding special stockholder meetings. Shareholder proposal | For | Against |
| December 15, 2025 | UniFirst Corporation | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Arnaud Ajdler Shareholder proposal | For | Against |
| December 15, 2025 | UniFirst Corporation | To elect two Class II directors, each to serve for a term of three years until the 2029 annual meeting of shareholders and until their respective successors are duly elected and qualified: Michael A. Croatti Shareholder proposal | For | Against |
| May 20, 2026 | Lumen Technologies, Inc. | Approval of a shareholder proposal regarding a shareholder right to vote for or against a poison pill. Shareholder proposal | For | Against |
| May 5, 2026 | SkyWest, Inc. | A shareholder proposal regarding collective bargaining policy. Shareholder proposal | For | Against |
| April 24, 2026 | ArcBest Corporation | A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposal | For | Against |
| May 12, 2026 | Group 1 Automotive, Inc. | Shareholder Proposal: Give Shareholders an Ability to Call for a Special Shareholder Meeting. Shareholder proposal | For | Against |
| June 3, 2026 | Resideo Technologies, Inc. | Shareholder Proposal Regarding Shareholder Right to Act by Written Consent. Shareholder proposal | For | Against |
Meetings with a proxy contest or competing nominees (13 in 2025-2026), and how the fund voted the items on its ballot.
15,699 ballot items at 2,029 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, EQ/Small Company Index Portfolio voted at 2,029 shareholder meetings of 1,910 companies, on 15,699 ballot items in all. Where management made a recommendation, the fund followed it on 98.4% of the items and voted against it 55 times. Its most frequent area of disagreement was director elections (23 of its votes against management). It voted on 56 shareholder proposals. It voted FOR the board's own proposals less often than Equitable's funds as a whole (79.1% against 92.5%). It voted differently from most Equitable funds on 2,747 items. 13 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.